反応式
Clc1ccnc(Cl)c1.Nc1ncco1>C1COCCO1.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.[Na+].[O-]c1ccccc1.[Pd].[Pd]>Clc1ccnc(Nc2ncco2)c1参加物
反応物 2
生成物 1
試薬・触媒・溶媒 4
反応条件
- 温度
- 80 °C
実験手順
To a flask containing 2,4-dichloropyridine (0.109 mL, 1.01 mmol), sodium phenolate (177 mg, 1.52 mmol), TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (11.60 mg, 0.01 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (17.59 mg, 0.03 mmol) (Xantphos), was added degassed dioxane (4 mL) and the mixture allowed to stir under nitrogen atmosphere for 5 min. To this solution was added oxazol-2-amine (94 mg, 1.11 mmol) and the reaction mixture was heated to 80 °C for three hours. A 1H NMR was measured of the crude reaction after the solvent had been removed. **This indicated the presence of significant amounts of 2,4-dichloropyridine as well as 2-amino oxazole**. LCMS of the crude reaction mixture at t= 90 min and at t= 3 h showed the desired product was present. The crude reaction mixture was dry loaded without workup and purified by automated flash chromatography.
出典と根拠
- ORDレコード
- ord-cab6249a1023430399dca1061d293aa8
- 出典データセット
- 750 AstraZeneca ELN dataset
- 元リンク
- 出典を表示
関連ノート
読み込み中…